Amerikanische Gesellschaft für Hirudotherapie

Evaluation of performance characteristics of the medicinal leech (Hirudo medicinalis) for the treatment of venous congestion

Experimental study published in Plast Reconstr Surg (2002)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Klinische StudienConforti ML et al. · Plastic and reconstructive surgery, 2002

Abstract

Medicinal leeches (Hirudo medicinalis) are a standard treatment for venous congestion, a complication that can occur after reconstructive surgery. If the cause of venous congestion cannot be surgically corrected, then medicinal leeches are used to temporarily increase perfusion levels and maintain physiologic requirements within the congested tissue. Leeches increase perfusion within congested tissue by actively drawing off blood as a bloodmeal. Furthermore, the leech bite continues to bleed and relieve congestion after detachment because of the anticoagulation effects of leech saliva left behind in the bite. In a porcine model, a 10 x 10 cm cutaneous flank flap was congested by clamping the venae comitantes. Four medicinal leeches were allowed to attach to the congested flap, and parameters of active feeding and passive bleeding after detachment were recorded. The average bloodmeal volume for the medicinal leeches was 2.45 ml. Average passive bleeding for the first 2 and 4 hours after leech detachment totaled 2.21 and 2.50 ml, respectively, with 90 percent of passive bleeding occurring within 5 hours after detachment. Laser Doppler imaging indicated that the spatial arrangement of surface perfusion increases were localized to a 1.6-cm-diameter circle around the leech head (bite) and corresponded well with the visual return of normal skin tones to the same area. This study provides a realistic and quantitative estimate of the spatial and volumetric characteristics of leech feeding and passive bleeding using a clinically relevant model of acute, severe congestion.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsBites and StingsBloodHemorrhageLaser-Doppler FlowmetryLeechesLeechingRegional Blood FlowSkinSurgical FlapsSwineVeins

Zusammenfassung

Porcine model showed leech bloodmeal averaged 2.45 mL, passive bleeding 2.50 mL over 4 hours, with surface perfusion increases localized to 1.6-cm circle around bite (90% bleeding within 5 hours of detachment).

Warum dies für die Hirudotherapie relevant ist

This study quantified the performance characteristics of medicinal leeches (Hirudo medicinalis) in a porcine model of acute venous congestion, created by clamping venae comitantes of a 10×10 cm cutaneous flank flap. Four leeches achieved an average bloodmeal volume of 2.45 ml, with passive bleeding averaging 2.50 ml over 4 hours post-detachment; 90% of passive bleeding occurred within 5 hours. Laser Doppler imaging showed perfusion increases localized to a 1.6-cm-diameter circle around the bite. This study is directly relevant to ASH, providing clinically useful volumetric and spatial parameters of leech-mediated blood removal. The limitation is that it is an animal model with a small number of leeches tested.

Zitation

Evaluation of performance characteristics of the medicinal leech (Hirudo medicinalis) for the treatment of venous congestion.

Conforti ML et al. · Plastic and reconstructive surgery, 2002

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.